GlassScriptPhysician profile
Megan R Collins
NPI 1417325879
$3,832.83
in general payments reported to CMS, 2019-2025
21 companies · $842 in 2025
The $842 reported for 2025 was more than what 80% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $526 · 2022: $521 · 2023: $1,061 · 2024: $883 · 2025: $842.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,766 · Education: $20.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,765.71 |
| Education | $20.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,427.11 | 2021-2025 | |
| Edwards Lifesciences Corporation | $387.10 | 2023-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Astrazeneca Pharmaceuticals LP | $302.85 | 2021-2023 | Farxiga |
| E.R. Squibb & Sons, L.L.C. | $286.50 | 2021-2025 | Camzyos, Eliquis |
| Amgen INC. | $286.40 | 2021-2025 | Repatha, Repatha |
| Pfizer INC. | $212.89 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $146.02 | 2021-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $143.59 | 2021-2025 | Jardiance |
| Janssen Pharmaceuticals, INC | $96.98 | 2021-2022 | |
| Philips North America LLC | $89.40 | 2023-2025 | (5044) Mcot, Extended Holter, Event |
| Baxter Healthcare | $66.20 | 2024-2025 | Hillrom - Cardiac Ambulatory Monitor |
| Astellas Pharma US INC | $65.00 | 2021 | |
| Merck Sharp & Dohme LLC | $60.67 | 2021-2023 | Verquvo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $58.54 | 2023 | Lifevest |
| Bridgebio Pharma, INC. | $55.53 | 2025 | Attruby |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heartflow, INC. | $49.27 | 2025 | |
| Alnylam Pharmaceuticals INC. | $30.01 | 2022 | |
| Kiniksa Pharmaceuticals, LTD. | $20.36 | 2023 | Arcalyst |
| Boston Scientific Corporation | $18.05 | 2021 | |
| Daiichi Sankyo INC. | $16.08 | 2025 | Injectafer |
| Amarin Pharma, INC. | $14.28 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Megan Collins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.